Literature DB >> 17406216

The gelatin sponge-chorioallantoic membrane assay.

Domenico Ribatti1, Beatrice Nico, Angelo Vacca, Marco Presta.   

Abstract

Here we present a method for the quantification of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane (CAM) based on the implantation of a gelatin sponge on the top of the growing CAM on day 8 of development. After implantation, the sponge is treated with a stimulator of blood vessel formation in the absence or presence of an angiogenesis inhibitor. On day 12, blood vessels that are growing into the sponge are counted at macroscopic and microscopic levels. The estimated timeline for carrying out this protocol is 10 d. The presence of a vascular network in the CAM requires a careful analysis to distinguish new capillaries from pre-existing ones. This limitation does not occur in the avascular cornea assay, which may also take advantage of different genetic backgrounds when carried out in transgenic or knockout mice. Nevertheless, the gelatin sponge-CAM assay is simple, inexpensive and suitable for large-scale screening.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17406216     DOI: 10.1038/nprot.2006.13

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  84 in total

1.  Pharmacological inhibition of Rho-kinase (ROCK) signaling enhances cisplatin resistance in neuroblastoma cells.

Authors:  Catharine A Street; Alissa A Routhier; Carrie Spencer; Ashley L Perkins; Katherine Masterjohn; Alexander Hackathorn; John Montalvo; Emily A Dennstedt; Brad A Bryan
Journal:  Int J Oncol       Date:  2010-11       Impact factor: 5.650

2.  45S5-Bioglass(®)-based 3D-scaffolds seeded with human adipose tissue-derived stem cells induce in vivo vascularization in the CAM angiogenesis assay.

Authors:  Marina Handel; Timo R Hammer; Patcharakamon Nooeaid; Aldo R Boccaccini; Dirk Hoefer
Journal:  Tissue Eng Part A       Date:  2013-08-12       Impact factor: 3.845

Review 3.  The chick chorioallantoic membrane (CAM) as a versatile patient-derived xenograft (PDX) platform for precision medicine and preclinical research.

Authors:  Logan C DeBord; Ravi R Pathak; Mariana Villaneuva; Hsuan-Chen Liu; Daniel A Harrington; Wendong Yu; Michael T Lewis; Andrew G Sikora
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

4.  Biodegradable electrospun nanofibers coated with platelet-rich plasma for cell adhesion and proliferation.

Authors:  Luis Diaz-Gomez; Carmen Alvarez-Lorenzo; Angel Concheiro; Maite Silva; Fernando Dominguez; Faheem A Sheikh; Travis Cantu; Raj Desai; Vanessa L Garcia; Javier Macossay
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2014-03-31       Impact factor: 7.328

5.  Repulsive axon guidance molecule Slit3 is a novel angiogenic factor.

Authors:  Bing Zhang; Ursula M Dietrich; Jian-Guo Geng; Roy Bicknell; Jeffrey D Esko; Lianchun Wang
Journal:  Blood       Date:  2009-09-09       Impact factor: 22.113

6.  EGFL6 promotes endothelial cell migration and angiogenesis through the activation of extracellular signal-regulated kinase.

Authors:  Shek Man Chim; An Qin; Jennifer Tickner; Nathan Pavlos; Tamara Davey; Hao Wang; Yajun Guo; Ming Hao Zheng; Jiake Xu
Journal:  J Biol Chem       Date:  2011-04-29       Impact factor: 5.157

7.  In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract.

Authors:  Irina Arnaoutova; Hynda K Kleinman
Journal:  Nat Protoc       Date:  2010-03-11       Impact factor: 13.491

8.  Fibroblast growth factor-2 binding to the thrombospondin-1 type III repeats, a novel antiangiogenic domain.

Authors:  Barbara Margosio; Marco Rusnati; Katiuscia Bonezzi; Blue-Leaf A Cordes; Douglas S Annis; Chiara Urbinati; Raffaella Giavazzi; Marco Presta; Domenico Ribatti; Deane F Mosher; Giulia Taraboletti
Journal:  Int J Biochem Cell Biol       Date:  2007-10-09       Impact factor: 5.085

9.  IL-25 dampens the growth of human germinal center-derived B-cell non Hodgkin Lymphoma by curtailing neoangiogenesis.

Authors:  Elisa Ferretti; Emma Di Carlo; Emanuela Ognio; Giulio Fraternali-Orcioni; Anna Corcione; Beatrice Belmonte; Jean Louis Ravetti; Claudio Tripodo; Domenico Ribatti; Vito Pistoia
Journal:  Oncoimmunology       Date:  2017-11-27       Impact factor: 8.110

10.  Non-peptidic thrombospondin-1 mimics as fibroblast growth factor-2 inhibitors: an integrated strategy for the development of new antiangiogenic compounds.

Authors:  Giorgio Colombo; Barbara Margosio; Laura Ragona; Marco Neves; Silvia Bonifacio; Douglas S Annis; Matteo Stravalaci; Simona Tomaselli; Raffaella Giavazzi; Marco Rusnati; Marco Presta; Lucia Zetta; Deane F Mosher; Domenico Ribatti; Marco Gobbi; Giulia Taraboletti
Journal:  J Biol Chem       Date:  2010-01-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.